FILE:AGN/AGN-8K-20100430093156.txt.gz
EVENTS:	Submission of Matters to a Vote of Security Holders
TEXT:
ITEM: Submission of Matters to a Vote of Security Holders
 
 
 
 
 
 
 
 
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
Item 5.07.    Submission of Matters to a Vote of Security Holders.
Allergan, Inc. (the "Company") held its Annual Meeting of Stockholders on April 29, 2010 and there were present in person or by proxy 256,751,876 votes, representing 84.42% of the total outstanding eligible votes. At the Annual Meeting, the Company's stockholders elected four directors to the Company's Board of Directors, ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for fiscal year 2010, and approved each of the four Company proposals regarding the Company's Restated Certificate of Incorporation, each as more fully described below.
: Election of four Class III directors to serve for three-year terms until the Company's annual meeting of stockholders in 2013
Item No. 1
The following directors continue to serve on the Board of Directors with terms expiring as set forth opposite their names:
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 


